Aberdeen Equity Long-Short Fund Class CMLSCX

6.33
0.03 / 0.47%
6.17 - 8.51+0.44
NAV in USDNAV change52-week range3-yr sharpe ratio
As of market close Apr 24 2015.

Total returns on $10,000

As of Mar 31 2015. Fund performance

Objective

The investment seeks long-term capital appreciation. The fund will invest at least 80% of the value of its net assets, plus any borrowings for investment purposes, in equity securities of companies that are organized under the laws of, or have their principal office in the United States, have their principal securities trading market in the United States, alone or on a consolidated basis derive the highest concentration of their annual revenue or earnings or assets from goods produced, sales made or services performed in the United States; and/or issue securities denominated in the currency of the United States.

Profile

Fund typeOpen Ended Investment Company
Investment style (stocks)
Market Cap: Large
Investment Style: Blend
Morningstar categoryLong/Short Equity
Launch date31/12/1997
Price currencyUSD
DomicileUnited States
SymbolMLSCX
Manager & start date
Douglas Burtnick
31/12/2004
Jason Kotik
31/12/2004
Francis Radano, III
31/12/2004
Paul Atkinson
31/12/2008
Ralph Bassett
31/12/2008

Investment

Pricing frequencyDaily
Total net assets
7.06m USDAs of Mar 31 2015
Net expense ratio2.25%
Front end load--
Deferred load1.00%
Redemption fee--
Min. initial investment1,000.00 USD
Min. additional investment50.00 USD
Initial IRA1,000.00 USD
Additional IRA50.00 USD
Available for saleUnited States

Diversification

Asset type

Cash
54.30%
US stock
39.64%
Non-US stock
6.06%
Other
0.00%
US bond
0.00%
Non-US bond
0.00%

Top 5 sectors

Healthcare
15.38%
Financial Services
14.44%
Industrials
12.29%
Technology
11.71%
Consumer Cyclical
8.94%

Top 5 Regions

United States
85.24%
Canada
6.14%
Sector and region weightings are calculated using only long position holdings of the portfolio.Sector & regional holdings

Top 5 holdings

Company1 year
change
Portfolio
weight
Long
allocation
CVS Health Corp
CVS:NYQ
+39.02%3.31%
Visa Inc Class A
V:NYQ
+28.90%3.20%
Cognizant Technology Solutions Corp Class A
CTSH:NSQ
+21.16%3.14%
Oracle Corporation
ORCL:NYQ
+8.38%3.02%
BorgWarner Inc
BWA:NYQ
-4.64%3.00%
Data delayed at least 15 minutes, as of Mar 31 2015. Top 10 holdings

The performance data shown in tables and graphs on this page is calculated in USD of the fund / index / average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.

All managed funds data located on FT.com is subject to the FT Terms & Conditions . All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2015
All Rights reserved

© 2015 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

The Morningstar Equity Style Box is a unique graphical tool showing a fund’s true investment style and market capitalisation.

The Morningstar Fixed Income Style Box is a unique graphical tool showing a fund's true credit quality and duration.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.